Here's Why Mallinckrodt Fell Over 17% Today

Here's Why Mallinckrodt Fell Over 17% Today

Source: 
Motley Fool
snippet: 

Shares of Mallinckrodt (NYSE: MNK) dropped as much as 17.3% today on multiple news items. The company reported that an appeals court has ruled that patents covering INOmax, the company's inhaled nitric oxide product, were not infringed upon by competing drug Noxivent from Praxair. That wasn't all.